SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-24-000046
Filing Date
2024-03-27
Accepted
2024-03-27 20:27:03
Documents
1
Period of Report
2024-03-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1711585608.html 4  
1 FORM 4 wk-form4_1711585608.xml 4 4144
  Complete submission text file 0001599298-24-000046.txt   5817
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CAREDX, INC. 1 TOWER PLACE, 9TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Dhingra Ankur (Reporting) CIK: 0001849682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 24793016